ATS (ATS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
9 Jul, 2026Executive summary
Fourth quarter bookings reached CAD 863 million, up 9% year-over-year, with full-year bookings at a record CAD 3.3 billion, driven by diversified growth and acquisitions.
Adjusted Q4 revenues were CAD 721 million, down 9% year-over-year, mainly due to lower EV revenues.
A negotiated settlement with an EV customer resulted in a CAD 194 million inflow, reducing net debt and providing financial flexibility, but also led to a significant one-time charge and net loss for the year.
Life sciences, energy, and consumer products segments showed strong backlogs and opportunity funnels, while transportation remained challenged but is expected to improve.
Recent acquisitions (Paxiom and Heidolph) contributed to growth in life sciences and food & beverage segments.
Financial highlights
Q4 adjusted revenues: CAD 721 million (down 8.9% year-over-year); Q4 adjusted earnings from operations: CAD 74.3 million (down 23% year-over-year); Q4 adjusted EBITDA: CAD 97.1 million (down 16.1% year-over-year).
Q4 adjusted EPS: $0.41, down from $0.65 last year; Q4 net loss: $(68.9) million versus net income of $48.5 million in Q4 F2024.
Fiscal 2025 adjusted revenues: $2,680.2 million, down from $3,032.9 million last year; adjusted EBITDA margin for the year was 13.8%.
Free cash flow for fiscal 2025 was negative $52.3 million, but Q4 free cash flow improved to $10.3 million from $(16.3) million year-over-year.
Net debt to pro forma adjusted EBITDA: 3.9x, expected to decrease after EV settlement.
Outlook and guidance
Fiscal 2026 Q1 revenue expected between CAD 680 million and CAD 730 million, supported by a robust order backlog.
Order backlog at quarter-end: CAD 2.1 billion, highest in eight quarters, supporting revenue visibility.
Book-to-bill ratio at 1.23, above 1 in all market verticals, indicating strong demand.
Margin expansion expected as transportation recovers and life sciences bookings convert to revenue, though inflation and supply chain volatility may impact short-term results.
Effective tax rate expected in the mid-20% range going forward.
Latest events from ATS
- Margin expansion, portfolio diversification, and disciplined M&A drive future growth.ATS
47th Annual Raymond James Institutional Investor Conference9 Jul 2026 - Q2 revenue fell 17% as transportation slumped, but record life sciences bookings and a $1.8B backlog support growth.ATS
Q2 20258 Jul 2026 - Life Sciences and digital services drive growth, with strong bookings and expanding recurring revenue.ATS
Citi's Global Industrial Tech and Mobility Conference 20258 Jul 2026 - C$3.0B adjusted revenue, strong M&A, and disciplined growth in automation markets.ATS
Investor presentation29 May 2026 - Revenue and earnings rose in fiscal 2026, with restructuring driving margin expansion.ATS
Q4 202628 May 2026 - Record financial results, all resolutions passed, and strategic focus on regulated markets.ATS
AGM 202419 May 2026 - Flexible shelf offering supports growth in automation for regulated, high-value markets.ATS
Registration filing27 Apr 2026 - C$2.9B adjusted revenues, 13.8% EBITDA margin, and robust M&A fuel global automation growth.ATS
Investor presentation19 Apr 2026 - Q3 revenue up 16.7%, net income surges, and strong backlog supports future growth.ATS
Q3 20264 Feb 2026